findmyKOL

Elizabeth Ferucci, MD

Basic profile

Alaska Native Tribal Health Consortium

ORCIDNPI
RegionAnchorage, AK · WestSpecialtyRheumatologyFocusRheumatology/Immunology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPaymentsNone reportedNIH funding2005–2026Why? →

Elizabeth Ferucci is a Rheumatology/Immunology physician affiliated with Alaska Native Tribal Health Consortium. OpenAlex indexes 86 publications with 2,313 citations (h-index 25).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
86publications

Distinct works indexed by OpenAlex, matched via ORCID.

2,313citations

Total citations across indexed works.

25h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
7NIH grants · 2005–2026

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

4315 Diplomacy Dr
Anchorage, AK 995085926

Telephone

907-729-1500

Provider last certified this registry record 3 Mar 2026.

View the NPPES registry record

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    62.3%
    Folate Analog Metabolic Inhibitor35.4%
    Methotrexate100%
    Part D16 patients
    Selective T Cell Costimulation Modulator12.6%
    Orencia50%Orencia Clickject50%
    Part D<11 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    22.9%
    Aminosalicylate12%
    Sulfasalazine100%
    Part D<11 patients
    Corticosteroid10.9%
    Prednisone100%
    Part D<11 patients
  • Antiparasitic

    14.9%
    Antimalarial14.9%
    Hydroxychloroquine Sulfate100%
    Part D<11 patients
Where care is delivered (Part B)67% facility · 33% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

7 NIH research awards on record, funded 20052026 per NIH RePORTER. The latest:

29 more award records behind the reveal.Reveal →

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”